Financhill
Back

Immunovant Vs. Perspective Therapeutics Industry Stock Comparison

Sell
32

IMVT
Immunovant

Last Price:
28.23
Seasonality Move:
8.47%
Buy
89

CATX
Perspective Therapeutics

Last Price:
1.50
Seasonality Move:
11.52%
Sell
32
Immunovant (IMVT) is a Sell

Is Immunovant a Buy, Sell or Hold?

  • The current Immunovant [IMVT] share price is $28.22. The Score for IMVT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • IMVT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
89
Perspective Therapeutics (CATX) is a Buy

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $1.50. The Score for CATX is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.
  • CATX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

IMVT Stock Price Chart

What is Immunovant's stock price today?

  • The Immunovant share price today is $28.22
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IMVT is experiencing slight buying pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $1.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

IMVT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.16 Sell
Relative Strength Index (14 RSI): 33.5 Sell
Chaikin Money Flow: 384752 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.63 - 32.03) Sell
Bollinger Bands (100): (32.06 - 40.96) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.1 Buy
Relative Strength Index (14 RSI): 61.91 Buy
Chaikin Money Flow: 3166590 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.19 - 1.51) Buy
Bollinger Bands (100): (0.4 - 1.22) Buy

IMVT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.61 Sell
20-day SMA: 30.7 Sell
50-day SMA: 33.03 Sell
200-day SMA: 31.92 Sell
8-day EMA: 29.38 Sell
20-day EMA: 30.5 Sell
50-day EMA: 32.58 Sell
200-day EMA: 31.23 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.48 Buy
20-day SMA: 1.4 Buy
50-day SMA: 1.16 Buy
200-day SMA: 0.6 Buy
8-day EMA: 1.47 Buy
20-day EMA: 1.39 Buy
50-day EMA: 1.18 Buy
200-day EMA: 0.73 Buy

Immunovant Earnings Growth & IMVT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.16 per share, and a decrease next year of $0.09 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Immunovant Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):